Previous Research

Over the last 30 years, the Foundation has supported by way of grants a diverse range of medical research projects.

These have included:

  • miR-127a as a biomarker and draggable target for radiotherapy resistance in breast cancer, Dr Tim Molloy (3 years)
  • Improving Chemotherapy Response Rates in Brain Cancer, Dr Lenka Munoz (3 years)
  • Towards an improved allergen immunotherapy vaccine targeting subtropical grass pollens, A/Prof Janet Davies (2 years)
  • The development of human hematopoietic prostaglandin D2 synthase inhibitors (HPGD2s) for allergic asthma, Prof Mark Smythe (1 year)
  • A potential new treatment for Alzheimer’s Disease from a snake venom, Dr Sanjaya Kuruppu (1 year)
  • Sphingolipid targeting agents in the treatment of cardiac fibrosis, A/Prof Bernard Flynn (1 year)
  • Towards new treatments for bacterial meningitis, Dr Andrew Mitchell (1 year)
  • Biomarker research for liver cancer, A/Prof Nicholas Shackel (3 years)
  • Chair in experimental ophthalmology, Save Sight Institute (15 years)
  • Personalised medicine in lung cancer, A/Prof Wendy Cooper (2 years)
  • Restoration of pathology specimens, Pathology Museum (15 years)
  • Research into ocular melanoma, Dr Max Conway (5 years)
  • Molecular changes in gliomas, Dr Michael Buckland (3 years)
  • Dry age-related macular degeneration, Dr Michele Madigan (3 years)
  • Winston Library: purchase of medical research books (29 years)
  • Personalise medicine for lung cancer and mesothelioma (2 years)
  • Multifocal visual evoked potentials in optic neuropathies: understanding the mechanism of axonal loss in optic neuritis and enhancing early detection of glaucoma. (3 years)
  • Role of MicroRNAs as regulators of cell survival and differentiation in acute myeloid leukaemia (3 years)
  • Early treatment of AIDS
  • Cancer of the prostate
  • Malignant tumors of the eye, focusing on childhood
  • The growth of malignant tissue cells outside the body and developing methods of modifying the activity of those cells without damaging normal cells
  • The mode of development of the lens of the eye and formation of cataracts
  • The relationship between some cancers and viruses
  • The early electronic diagnosis of glaucoma and the accurate monitoring of progress, reducing the risk of blindness
  • The accurate definition and tracking of nerve fibres from the eye to the brain and the influence of those fibres on the interpretation, by the brain, of the visual signals
  • Funding the internet enablement of the South Eastern Sydney Illawarra Health’s Service’s electronic medical library
  • Prevention of bony Metastases in Prostate and Breast cancers
  • Chemical induced Neurotoxicity in Cancer treatment
  • Vascular growth and tumour invasion in retinoblastoma and ureal melanoma
  • Research fellowship at the Save Sigh Institute, Sydney Hospital
  • Molecular profiling re myeloid leukaemia
  • Gene expression profiling of lymphoma

 

make-a-donation

partner-enquiry

thinking-out-land

Loading

Looking beyond the research and considering translational needs when funding research. How well are your expectations, application and review processes, measures of success and funding strategy aligned with the next steps for translation?

Thank you for voting
You have already voted on this poll!
Please select an option!

    Supporters